1074-82-4|Potassium 1,3-dioxoisoindolin-2-ide| Ambeed

Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

{[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

Quality Control of [ 1074-82-4 ] Purity: 98% SDS Specification

COA

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

NMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

CNMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

HPLC

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

LC-MS

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

1-2 Day Shipping
High Quality
Technical Support

Product Details of [ 1074-82-4 ]

CAS No. :	1074-82-4
Formula :	C₈H₄KNO₂
M.W :	185.22
SMILES Code :	O=C(C1=C2C=CC=C1)[N-]C2=O.[K+]
MDL No. :	MFCD00005887
InChI Key :	FYRHIOVKTDQVFC-UHFFFAOYSA-M
Pubchem ID :	3356745

Safety of [ 1074-82-4 ]

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319
Precautionary Statements:	P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Computational Chemistry of [ 1074-82-4 ] Show Less

Physicochemical Properties

Num. heavy atoms	12
Num. arom. heavy atoms	6
Fraction Csp3	0.0
Num. rotatable bonds	0
Num. H-bond acceptors	3.0
Num. H-bond donors	0.0
Molar Refractivity	40.86
TPSA ? Topological Polar Surface Area: Calculated from Ertl P. et al. 2000 J. Med. Chem.	34.14 Å²

Lipophilicity

Log P_o/w (iLOGP)? iLOGP: in-house physics-based method implemented from Daina A et al. 2014 J. Chem. Inf. Model.	-8.96
Log P_o/w (XLOGP3)? XLOGP3: Atomistic and knowledge-based method calculated by XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry	1.15
Log P_o/w (WLOGP)? WLOGP: Atomistic method implemented from Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.	0.97
Log P_o/w (MLOGP)? MLOGP: Topological method implemented from Moriguchi I. et al. 1992 Chem. Pharm. Bull. Moriguchi I. et al. 1994 Chem. Pharm. Bull. Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.	1.65
Log P_o/w (SILICOS-IT)? SILICOS-IT: Hybrid fragmental/topological method calculated by FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com	1.55
Consensus Log P_o/w? Consensus Log P_o/w: Average of all five predictions	-0.73

Water Solubility

Log S (ESOL):? ESOL: Topological method implemented from Delaney JS. 2004 J. Chem. Inf. Model.	-2.08
Solubility	1.53 mg/ml ; 0.00826 mol/l
Class? Solubility class: Log S scale Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly	Soluble
Log S (Ali)? Ali: Topological method implemented from Ali J. et al. 2012 J. Chem. Inf. Model.	-1.46
Solubility	6.4 mg/ml ; 0.0346 mol/l
Class? Solubility class: Log S scale Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly	Very soluble
Log S (SILICOS-IT)? SILICOS-IT: Fragmental method calculated by FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com	-2.76
Solubility	0.325 mg/ml ; 0.00175 mol/l
Class? Solubility class: Log S scale Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly	Soluble

Pharmacokinetics

GI absorption? Gatrointestinal absorption: according to the white of the BOILED-Egg	High
BBB permeant? BBB permeation: according to the yolk of the BOILED-Egg	Yes
P-gp substrate? P-glycoprotein substrate: SVM model built on 1033 molecules (training set) and tested on 415 molecules (test set) 10-fold CV: ACC=0.72 / AUC=0.77 External: ACC=0.88 / AUC=0.94	Yes
CYP1A2 inhibitor? Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set) and tested on 3000 molecules (test set) 10-fold CV: ACC=0.83 / AUC=0.90 External: ACC=0.84 / AUC=0.91	No
CYP2C19 inhibitor? Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set) and tested on 3000 molecules (test set) 10-fold CV: ACC=0.80 / AUC=0.86 External: ACC=0.80 / AUC=0.87	No
CYP2C9 inhibitor? Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set) and tested on 2075 molecules (test set) 10-fold CV: ACC=0.78 / AUC=0.85 External: ACC=0.71 / AUC=0.81	No
CYP2D6 inhibitor? Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set) and tested on 1068 molecules (test set) 10-fold CV: ACC=0.79 / AUC=0.85 External: ACC=0.81 / AUC=0.87	No
CYP3A4 inhibitor? Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set) and tested on 2579 molecules (test set) 10-fold CV: ACC=0.77 / AUC=0.85 External: ACC=0.78 / AUC=0.86	No
Log Kp (skin permeation)? Skin permeation: QSPR model implemented from Potts RO and Guy RH. 1992 Pharm. Res.	-6.61 cm/s

Druglikeness

Lipinski? Lipinski (Pfizer) filter: implemented from Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev. MW ≤ 500 MLOGP ≤ 4.15 N or O ≤ 10 NH or OH ≤ 5	0.0
Ghose? Ghose filter: implemented from Ghose AK. et al. 1999 J. Comb. Chem. 160 ≤ MW ≤ 480 -0.4 ≤ WLOGP ≤ 5.6 40 ≤ MR ≤ 130 20 ≤ atoms ≤ 70	None
Veber? Veber (GSK) filter: implemented from Veber DF. et al. 2002 J. Med. Chem. Rotatable bonds ≤ 10 TPSA ≤ 140	0.0
Egan? Egan (Pharmacia) filter: implemented from Egan WJ. et al. 2000 J. Med. Chem. WLOGP ≤ 5.88 TPSA ≤ 131.6	0.0
Muegge? Muegge (Bayer) filter: implemented from Muegge I. et al. 2001 J. Med. Chem. 200 ≤ MW ≤ 600 -2 ≤ XLOGP ≤ 5 TPSA ≤ 150 Num. rings ≤ 7 Num. carbon > 4 Num. heteroatoms > 1 Num. rotatable bonds ≤ 15 H-bond acc. ≤ 10 H-bond don. ≤ 5	1.0
Bioavailability Score? Abbott Bioavailability Score: Probability of F > 10% in rat implemented from Martin YC. 2005 J. Med. Chem.	0.55

Medicinal Chemistry

PAINS? Pan Assay Interference Structures: implemented from Baell JB. & Holloway GA. 2010 J. Med. Chem.	0.0 alert
Brenk? Structural Alert: implemented from Brenk R. et al. 2008 ChemMedChem	1.0 alert: heavy_metal
Leadlikeness? Leadlikeness: implemented from Teague SJ. 1999 Angew. Chem. Int. Ed. 250 ≤ MW ≤ 350 XLOGP ≤ 3.5 Num. rotatable bonds ≤ 7	No; 1 violation:MW<1.0
Synthetic accessibility? Synthetic accessibility score: from 1 (very easy) to 10 (very difficult) based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties, trained on 12'782'590 molecules and tested on 40 external molecules (r² = 0.94)	1.1

Application In Synthesis of [ 1074-82-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Upstream synthesis route of [ 1074-82-4 ]
Downstream synthetic route of [ 1074-82-4 ]

[ 1074-82-4 ] Synthesis Path-Upstream 1~1

1
[ 1252018-10-2 ]
[ 1074-82-4 ]
[ 446292-07-5 ]

Yield	Reaction Conditions	Operation in experiment
93%	at 20 - 100℃; for 3 h;	Example 3:Preparation of 2-((2R)-2-Hydroxy-3-[4-(3-oxomorpholin-4-yl)- phenyl]amino}proply)-1 /-/-isoindole-1 ,3(2H)-dione (7a): Potassium phthalimide (7.16 g, 38.632 mmoL) was added in one portion to a mechanically stirred mixture of 4-[4-(N-(3-chloro-2R-hydroxy-1-propyl)amino)phenyl]morpholin-3- one (10 g, 35.119 mmoL) in DMF (60 mL). The suspension was stirred at room temperature and was heated to 100 °C, stirred at that temperature for 3 h and then cooled to room temperature. Water (60 mL) was charged and the suspension stirred for another 15 min. The suspension was filtered through a Buchner funnel. The solid was washed with water (2 x 40 mL) and dried under vacuum at 50°C for 10 h to yield 2-((2f?)-2-Hydroxy-3-[4-(3-oxomorpholin-4- yl)-phenyl]amino}proply)-1 7-isoindole-1 ,3(2/-/)-dione (12.55 g, 93percent) as a crystalline white solid.¹HNMR (400MHz, DMSO-d6) δ 2.99-3.05 (m, 1 H), 3.14-3.2 (m, 1 H), 3.59-3.69 (m, 4H), 3.91-3.94 (m, 2H), 3.97-4.05 (m, 1 H), 4.14 (s, 2H), 5.16 (d, J=5.2 Hz, 1 H), 5.66 (t, J=6.0 Hz, 1 H), 6.61 (d, J=8.7 Hz, 2H), 7.03 (d, J=8.8 Hz, 2H), 7.82-7.88 (m, 4H).
92%	Stage #1: With sodium hydroxide In dichloromethane; water at 20℃; for 8 h; Stage #2: at 100℃; for 3 h;	The above 57.6 g of intermediate 4 and 400 mL of dichloromethane were charged into a 1 L three-necked flask,A solution of 17.8 g of Na0H and 60 mL of water was added dropwise at room temperature,After stirring at room temperature for 6 h, the organic layer was washed with 120 mL of water and then with 60 mL of saturated brine,The organic layer was dried over anhydrous sodium sulfate,Filtered, concentrated to 180mL of liquid, by adding 360mL n-hexane heated reflux 30min,System cooling to room temperature and then stirring 2h,The filter cake was washed with dichloromethane and n-hexane (1: 3)The filter cake was dried in vacuo for 12 h to give 48.2 g of white crystals.48 g (0.17 mol) of the above solid and 240 mL of the 4-dioxane were charged into a 500 mL three-necked flask,34.4 g (0.19 mol) of potassium phthalimide potassium salt was added with stirring,System gradually heated to 100 ° C, stirring 3h, cooling to room temperature, add 60mL water stirring 15min,Filter, filter cake washed with 2X1 OOmL,White crystals were obtained at 50 ° C in vacuum and dried 1 Oh to give 60.2 g of compound 6 (92percent) mp. = 211.7-211.9 ° C.
87.8%	for 10 h; Reflux	The reaction flask, and the resulting 32.7g (0.115mol) of intermediate V with 300ml of anhydrous methanol was dissolved, followed by addition of 29.1g (0.157mol) of potassium phthalimide and heated at reflux for 9 hours, TLC in the control (ethyl acetate: methanol = 10: 1, volume ratio) to complete the reaction, filtered hot, the filtrate was lowered to room temperature (about 25 ) was stirred for 2 hours, filtered, the filter cake was rinsed with 75ml of anhydrous methanol, and drying under reduced pressure, intermediate VI to give an off-white about 39.9g (0.101mol), intermediate V molar yield intermediate VI is prepared from about 87.8percent.

87.8%	for 9 h; Reflux	In the reaction flask, the obtained 32.7 g (0.115 mol) of the intermediate V was dissolved with 300 ml of anhydrous methanol,Then, 29.1 g (0.157 mol) of potassium phthalimide was added and the mixture was heated to reflux for 9 hours.The reaction was completed by TLC (ethyl acetate:methanol=10:1, volume ratio) and the reaction was complete. The filtrate was cooled to room temperature (about 25° C.) and stirred for 2 hours. The mixture was filtered, and the filter cake was rinsed with 75 ml of anhydrous methanol. drying,About 39.9 g (0.101 mol) of the off-white intermediate VI was obtained, and about 87.8percent of the intermediate V was produced in the molar yield of the intermediate VI.
51.4 g	for 10 h; Reflux	In the reaction flask, the obtained 42.6 g (0.15 mol)Intermediate V was dissolved with 400 ml anhydrous methanol.Then 38.8 g (0.21 mol) of potassium phthalimide was added,The mixture was heated at reflux for 10 hours, and the reaction was completed by TLC (ethyl acetate: methanol = 10:1, volume ratio).Heat filtered, the filtrate was cooled to room temperature (about 25°C) and stirred for 2 hours, filtered,The filter cake was rinsed with 100 ml of anhydrous methanol and dried under reduced pressure to obtain about 51.4 g (0.13 mol) of the off-white intermediate VI. The intermediate V produced the intermediate VI in a molar yield of about 86.7percent.

References: [1] Patent: WO2012/51692, 2012, A1, . Location in patent: Page/Page column 42-43.
[2] Patent: CN103951661, 2017, B, . Location in patent: Paragraph 0043-0044.
[3] Patent: CN104974105, 2017, B, . Location in patent: Paragraph 0073.
[4] Patent: CN104974149, 2018, B, . Location in patent: Paragraph 0074; 0075; 0077; 0081; 0083.
[5] Patent: WO2012/32533, 2012, A2, . Location in patent: Page/Page column 15.
[6] Patent: CN104974148, 2017, B, . Location in patent: Paragraph 0073; 0074; 0076; 0082.

[ 1074-82-4 ] Synthesis Path-Downstream 1~27

1
[ 558-42-9 ]
[ 1074-82-4 ]
[ 167108-05-6 ]

Yield	Reaction Conditions	Operation in experiment
37%	With sodium iodide; In N,N-dimethyl-formamide;Heating / reflux;	A solution of 1-chloro-2-methyl-2-propanol (2.23 g, 97percent, 0.02 mol), potassium phthalimide (3.780 g, 98percent, 0.02 mol) and sodium iodide (60 mg, 4 mmol) in anhydrous DMF (40 mL) was heated to reflux overnight. The solvent was evaporated under reduced pressure. The resulting product was triturated with a mixture of 3:2 ethyl acetate/hexanes and the ensuing white precipitate was removed by filtration. The yellow filtrate was concentrated under reduced pressure and purified by flash chromatography in a mixture of 2:3 ethyl acetate/hexanes. The impure product thus isolated was triturated with hot hexanes (125 mL) and filtered to remove an insoluble white impurity. After evaporation of the solvent under reduced pressure, the obtained white solid was recrystallized in hexanes. The product was yielded as colorless crystals that were collected by filtration and dried under high vacuum (1.63 g, 37percent yield). m.p.: 104-105° C.; TLC Rf 0.20 (2:3 ethyl acetate/hexanes); FTIR (KBr): 3524, 3456, 3097, 3031, 2973, 2930, 1773, 1698, 1611, 1466, 1427, 1389, 1319, 1190, 1076, 990, 965, 912, 890, 838, 766, 724, 712, 638 cm-1; 1H-NMR(500 MHz, CDCl3): delta 1.26 (s, 6H, 2 CH3), 2.74 (s, 1H, OH), 3.75 (s, 2H, CH2), 7.72 (dd, 2H, Jo=5.44 Hz, Jm=3.04 Hz, 2 Hc),, 7.85 (dd, 2H, Jo=5.42 Hz, Jm=3.06 Hz, 2 Hb); 13C-NMR(126 MHz, CDCl3): delta 27.6 (2 CH3), 49.3 (CH2), 71.6 (CMe2), 123.6 (2 Cb), 132.0 (2 Ca), 134.3 (2 Cc), 169.3 (2 CO).

References: [1]Patent: US2008/102028,2008,A1 .Location in patent: Page/Page column 9; 10.
[2]Chemische Berichte,1921,vol. 54,p. 3160.

2
[ 34270-90-1 ]
[ 1074-82-4 ]
[ 43113-25-3 ]

References: [1]Chemische Berichte,1905,vol. 38,p. 3413.

3
[ 14704-31-5 ]
[ 1074-82-4 ]
[ 858443-07-9 ]

References: [1]Journal of the Chemical Society,1933,p. 37,39.

4
[ 2895-21-8 ]
[ 1074-82-4 ]
[ 99275-58-8 ]

References: [1]Journal of Heterocyclic Chemistry,1985,vol. 22,p. 577 - 581.

5
[ 10226-29-6 ]
[ 1074-82-4 ]
[ 71510-41-3 ]

References: [1]Journal of Organic Chemistry,2005,vol. 70,p. 2067 - 2074.

6
[ 1074-82-4 ]
[ 85482-13-9 ]
[ 793695-86-0 ]

References: [1]Journal of Medicinal Chemistry,2005,vol. 48,p. 1745 - 1758.

7
[ 1074-82-4 ]
[ 169048-83-3 ]
[ 352524-58-4 ]

References: [1]Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry,2006,vol. 45,p. 1264 - 1268.

8
[ 439134-78-8 ]
[ 1074-82-4 ]
[ 929693-86-7 ]

References: [1]Journal of Medicinal Chemistry,2007,vol. 50,p. 685 - 695.

9
[ 74733-30-5 ]
[ 1074-82-4 ]
[ 165528-70-1 ]

Yield	Reaction Conditions	Operation in experiment
	In N-methyl-acetamide;	a) methyl 4-(phthalimidomethyl)-3-chlorobenzoate A mixture of <strong>[74733-30-5]methyl 4-bromomethyl-3-chlorobenzoate</strong> 10 g, 38 mmol) and potassium phthalimide (9.85 g, 53 mmol) in dimethylformamide (65 mL) was stirred and heated to 85 C. for 2 h. The hot mixture was poured into ice water and the resulting solid was filtered, washed sequentially with water, ethanol and a small amount of ether and dried to give the title compound.

References: [1]Patent: US6403578,2002,B1 .

10
[ 1074-82-4 ]
[ 103347-14-4 ]
[ 169045-07-2 ]

Yield	Reaction Conditions	Operation in experiment
	In N-methyl-acetamide;	PREPARATION 91(3) To a solution of <strong>[103347-14-4]4-chloro-3-methoxybenzyl bromide</strong> (7.00 g) in anhydrous dimethylformamide (50 mL) was added potassium phthalimide (6.03 g), and the mixture was stirred for 2 hours at ambient temperature. The mixture was partitioned between ethyl acetate and water. The separated organic layer was washed with water and brine, dried over magnesium sulfate and evaporated in vacuo. The residue was triturated with diisopropyl ether to give N-(4-chloro-3-methoxybenzyl)phthalimide as white powders (5.88 g). NMR (CDCl3, delta): 3.90 (3H, s), 4.80 (2H, s), 6.96 (1H, d, J=8 Hz), 7.05 (1H, s), 7.25-7.31 (1H, m), 7.68-7.75 (2H, m), 7.82-7.90 (214, m).

References: [1]Patent: US6384080,2002,B1 .

11
[ 3913-23-3 ]
[ 1074-82-4 ]
[ 180080-49-3 ]

Yield	Reaction Conditions	Operation in experiment
94%	With hydrogenchloride; In N-methyl-acetamide; water; ethyl acetate;	Example 117 Synthesis of N-(2-methoxy-5-nitrophenylmethyl)phthalimide Potassium phthalimide (836 mg) was added to a solution of <strong>[3913-23-3]2-methoxy-5-nitrobenzyl bromide</strong> (1.01 g) in dimethylformamide (41 ml) and stirred at room temperature for 10 minutes. Water and 2 N HCl were added to the reaction mixture and extraction was performed with ethyl acetate; then, the organic layer was washed successively with a saturated aqueous sodium bicarbonate solution and a saturated aqueous sodium chloride solution, dried with anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was washed successively with ethyl acetate and hexane to give 1.2 g of the titled compound (yield, 94%). 1H-NMR(DMSO-d6) delta: 3.97(3H,s), 4.80(2H,s), 7.26(1H, d, J=9.3 Hz), 7.82-7.93(4H,m), 7.99(1H, d, J=2.9 Hz), 8.40(1H, dd, J=9.3, 2.9 Hz)

References: [1]Patent: US6534546,2003,B1 .

12
[ 20587-30-8 ]
[ 1074-82-4 ]
[ 161292-80-4 ]

Yield	Reaction Conditions	Operation in experiment
33%	With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile); In tetrachloromethane; ethyl acetate; N,N-dimethyl-formamide; toluene;	1 Methyl 5-phthalimidomethyl-2-nitrobenzoate A mixture of <strong>[20587-30-8]methyl 5-methyl-2-nitrobenzoate</strong> (35.0 g, 179 mmol), N-bromosuccinimide (33.5 g, 188 mmol), and azobisisobutyronitrile (500 mg) in carbon tetrachloride (450 mL) was refluxed for 14 h. The insoluble material formed was removed by filtration and the filtrate was concentrated. The residue was dissolved in DMF (300 mL) and potassium phthalimide (19.41 g, 45 mmol) was added. The mixture was stirred for 2 h at 50 C., poured into brine, and extracted with a 1:1 mixture of toluene and ethyl acetate. The organic layers were washed with brine, dried over magnesium sulfate, and concentrated. The residue was purified by silica gel column chromatography with 4:1 to 2:1 hexane/ethyl acetate to give 20.0 g of the title compound (33%). 1 H NMR (CDCl3) delta7.85~7.92 (m, 3H), 7.73~7.80 (m, 3H), 7.68 (dd, 1H, J=8.2, 2.0 Hz), 4.92 (s, 2H), 3.91 (s, 3H).

References: [1]Patent: US5719152,1998,A .

13
[ 18742-02-4 ]
NH₂NH_2.H₂O [ No CAS ]
Bu₄N+HSO₄- [ No CAS ]
[ 1074-82-4 ]
[ 5754-35-8 ]

Yield	Reaction Conditions	Operation in experiment
73%	In ethanol; toluene;	A) 2-(2-Aminoethyl)-1,3-dioxolane A suspension of 50 g of 2-(2-bromoethyl)-1,3-dioxolane (product known in literature, CAS RN = 5754-35-8) (0.27 mL, 32.5 mol), 62.5 g of potassium phthalimide (0.34 mol), 9.16 g of Bu4N+HSO4- (0.027 mol) in 150 ml of toluene was heated to 100C and under N2 stream for 3 h. After cooling to room temperature, the mixture was filtered and evaporated to dryness. By crystallization of the residue from abs. EtOH the phthalimido derivative was obtained. A solution of 58.5 g of NH2NH2.H2O (1.17 ml; 56.8 mol), 64.36 g of phthalimido derivative (0.26 mol) in 2 l of abs. EtOH was heated to reflux under N2 stream for 2.5 h. After cooling to 0C, the precipitated phthalhydrazide was filtered through a sintered funnel. By evaporation of the filtrate to dryness, 23.26 g of the desired product (0.198 mol) were obtained. Yield: 73% The 1H-NMR, 13C-NMR, IR and MS spectra are consistent with the indicated structure.

References: [1]Patent: EP760683,2000,B1 .

14
[ 101990-45-8 ]
[ 1074-82-4 ]
[ 120740-11-6 ]

References: [1]Journal of Agricultural and Food Chemistry,2008,vol. 56,p. 204 - 212.

15
[ 27311-65-5 ]
[ 1074-82-4 ]
[ 1355450-11-1 ]

References: [1]Inorganic Chemistry,2012,vol. 51,p. 1859 - 1865.

16
[ 1074-82-4 ]
[ 2142-04-3 ]

References: [1]Tetrahedron Letters,2013,vol. 54,p. 6012 - 6014.
[2]Tetrahedron Letters,2013,vol. 54,p. 6012 - 6014.
[3]Tetrahedron Letters,2013,vol. 54,p. 6012 - 6014.
[4]Tetrahedron Letters,2013,vol. 54,p. 6012 - 6014.
[5]Tetrahedron Letters,2013,vol. 54,p. 6012 - 6014.

17
[ 1074-82-4 ]
[ 51997-51-4 ]
2-[3-(9H-carbazol-5-yloxy)-2-hydroxypropyl]-1H-isoindole-1,3(2H)-dione [ No CAS ]

References: [1]Indian Journal of Heterocyclic Chemistry,2012,vol. 21,p. 251 - 254.

18
[ 4018-65-9 ]
[ 70987-78-9 ]
[ 1074-82-4 ]
[ 98-59-9 ]
C₁₇H₁₂ClNO₄ [ No CAS ]